CardiaTec

Advancing cardiovascular research with AI.

Edited:

📋 Overview of CardiaTec

Founding Year

2021

Estimated Funding

$0000

Size

$0000

Locations

Cambridge

Primary Industry

Biotechnology, Industry

📙 About CardiaTec

CardiaTec Biosciences focuses on decoding cardiovascular biology through advanced data-driven approaches. It leverages machine learning and multi-omics data, aiming to uncover novel insights into the underlying mechanisms of heart disease. This enables the development of more precise therapeutic interventions and diagnostics for cardiovascular conditions. It helps accelerate cardiovascular research and opens new avenues for treating heart-related diseases.

💰 Recent Investors of CardiaTec

APEX Ventures, Continuum Health Ventures, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.